'Could Put Us Out Of Business’: US State Bill Pileup Has Small Beauty Set On Federal Preemption
The cosmetics industry has an “optics” problem, and that is creating other issues, namely a growing body of state legislation to address perceived gaps in federal regulatory oversight.
You may also be interested in...
Bundled within the draft FDA Safety and Landmark Enhancements Act are federal cosmetics reform provisions that would require facility registration and product listings with the US FDA, adverse event reporting and good manufacturing practices, while empowering the agency to order product recalls, access company records, and suspend dangerous operations.
After freezing its routine inspection activities at the height of the COVID-19 pandemic, the FDA adapted its oversight approach visibly in the drug and medical devices sectors, including with voluntary remote regulatory assessments. The agency now seeks authority to continue that work on a non-voluntary basis across all FDA-regulated programs.
The Zero Mercury Working Group, an international coalition of NGOs formed in 2005 by the European Environmental Bureau and the Mercury Policy Project, says e-commerce platforms including Amazon and eBay are not doing enough to keep illegal products off their sites, underscoring need for tougher regulations.